Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?
Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, VAN DEN Bergh RC, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: fourcade a. Minerva Urol Nephrol. 2023 Feb;75(1):124-126. doi: 10.23736/S2724-6051.22.05121-7. Epub 2022 Oct 25. Minerva Urol Nephrol. 2023. PMID: 36282548 Free article. No abstract available.
Évaluation du « Quadrella » a 2ans : nouvel indice de performance oncologique et fonctionnelle spécifique de la curiethérapie prostatique.
Coquet J, Delage F, Perrouin-Verbe M, Malhaire J, Schoentgen N, Fourcade A, Rousseau B, Thoulouzan M, Callerot P, Fournier G, Valeri A. Coquet J, et al. Among authors: fourcade a. Prog Urol. 2015 Nov;25(13):836-7. doi: 10.1016/j.purol.2015.08.242. Prog Urol. 2015. PMID: 26544435 French. No abstract available.
Evaluation of the "Quadrella" at 3 years: New index to assess functional and oncological performance specific to prostate brachytherapy.
Coquet JB, Delage F, Fourcade A, Callerot P, Goasduff G, Boussion N, Rousseau B, Serey-Eiffel S, Malhaire JP, Pradier O, Schick U, Fournier G, Valeri A. Coquet JB, et al. Among authors: fourcade a. Brachytherapy. 2018 Sep-Oct;17(5):782-787. doi: 10.1016/j.brachy.2018.05.007. Epub 2018 Jun 21. Brachytherapy. 2018. PMID: 29936129
Prospective four years of evaluation of erectile function after low-dose-rate prostate brachytherapy using baseline IIEF-5 > 16.
Schoentgen N, Marolleau J, Delage F, Coquet JB, Fourcade A, Callerot P, Serey-Eiffel S, Malhaire JP, Pradier O, Schick U, Fournier G, Valeri A. Schoentgen N, et al. Among authors: fourcade a. J Contemp Brachytherapy. 2019 Jun;11(3):195-200. doi: 10.5114/jcb.2019.85793. Epub 2019 Jun 28. J Contemp Brachytherapy. 2019. PMID: 31435425 Free PMC article.
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.
Diamand R, Oderda M, Albisinni S, Fourcade A, Fournier G, Benamran D, Iselin C, Fiard G, Descotes JL, Assenmacher G, Svistakov I, Peltier A, Simone G, Di Cosmo G, Roche JB, Bonnal JL, Van Damme J, Rossi M, Mandron E, Gontero P, Roumeguère T. Diamand R, et al. Among authors: fourcade a. Urol Oncol. 2020 Nov;38(11):847.e9-847.e16. doi: 10.1016/j.urolonc.2020.04.011. Epub 2020 May 26. Urol Oncol. 2020. PMID: 32466877
100 results